Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: São Paulo Advanced School of Comparative Oncology: Abstracts

Open Access Open Badges Poster presentation

Hemangiosarcoma and its cancer stem cell sub-population are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors

Jill T Schappa*, Aric M Frantz, Brandi H Gorden, Erin B Dickerson, Daniel A Vallera and Jaime F Modiano

BMC Proceedings 2013, 7(Suppl 2):P34  doi:10.1186/1753-6561-7-S2-P34

No comments have yet been made on this article.

Post a comment